ARCHIVES

Chemo Combinations Tested In Phase III For Lung Cancer

This article is from The Cancer Letter archive.

Vol. 24 No. 8 | August 31, 2001

Download PDF Visit The Full Archive

Related Articles

Risk of Relapse Continues After Five Years of Therapy

August 29, 2008

ACS To Continue Supporting Both Treatment, Prevention Research, Leaders Say

May 1, 1987

Central Line Safety Intervention Lowers Patient Infection Rate

October 25, 2013

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

May 25, 2012

Avastin May Trigger Two FDA Decisions: One On Approval, Another On Withdrawal

September 3, 2010

In Brief: House Rumored To Cut NIH Budget By $146 Mil,; Okays Pacific Yew Act; 471 Nurses Pass Exam

July 24, 1992